Trials in intracerebral haemorrhage: a path to success?
- PMID: 37353268
- DOI: 10.1016/S1474-4422(23)00201-6
Trials in intracerebral haemorrhage: a path to success?
Conflict of interest statement
LS has received research grants and honoraria from the UK Medical Research Council, and Takeda China, Hastenpharma, and Penumbra, paid to her institution. XC has received fellowship grant support from the National Heart Foundation of Australia. We thank Craig Anderson for comments on this manuscript.
Comment on
-
Desmopressin for patients with spontaneous intracerebral haemorrhage taking antiplatelet drugs (DASH): a UK-based, phase 2, randomised, placebo-controlled, multicentre feasibility trial.Lancet Neurol. 2023 Jul;22(7):557-567. doi: 10.1016/S1474-4422(23)00157-6. Lancet Neurol. 2023. PMID: 37353276 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
